Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/11/2020
SIETES contiene 93175 citas

 
 
 1 a 5 de 5 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Shlipak MG, Coresh J, Gansevoort RT. Cystatin C versus creatinine for kidney function-based risk. The authors reply. N Engl J Med 2013;369:2459. [Ref.ID 96682]
2.Tiene citas relacionadas Cita con resumen
Shlipak MG, Mathushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, for the CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013;369:932-43. [Ref.ID 96070]
3.Tiene citas relacionadas Cita con resumen
Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghome KR, Shankar A, Smith DH, Tonelli M, Wamock DG, Wen C-P, Coresh J, Gansevoort RT, Hemmelgam BR, Levey AS, for the Chronic Kidney Disease Prognosis Consortium. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012;307:1941-51. [Ref.ID 92860]
4.
Atthobari J, Gansevoort RT, Vísser ST, de Jong PE, de Jong-van den Berg LTW, on behalf of the PREVEND study group. The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate. Br J Clin Pharmacol 2007;63:224-31. [Ref.ID 79127]
5.Tiene citas relacionadas
Gansevoort RT, van Veldhuisen DJ. Comparison of losartan and captopril in ELITE II. Lancet 2000;356:851-2. [Ref.ID 52577]
Seleccionar todas
 
 1 a 5 de 5